0001104659-19-039996.txt : 20190712 0001104659-19-039996.hdr.sgml : 20190712 20190712060535 ACCESSION NUMBER: 0001104659-19-039996 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190712 DATE AS OF CHANGE: 20190712 EFFECTIVENESS DATE: 20190712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Versant Venture Management, LLC CENTRAL INDEX KEY: 0001560009 IRS NUMBER: 954767945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16849 FILM NUMBER: 19952012 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET, SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 13F-HR 1 primary_doc.xml 13F-HR LIVE 0001560009 XXXXXXXX 06-30-2019 06-30-2019 false Versant Venture Management, LLC

One Sansome Street, Suite 3630 San Francisco CA 94104

13F HOLDINGS REPORT 028-16849 N Robin L. Praeger (415) 801-8100 /s/ Robin L. Praeger San Francisco CA 07-12-2019 0 9 343186488 false INFORMATION TABLE 2 a19-12752_1informationtable.xml INFORMATION TABLE Clovis Oncology, Inc. Common Stock 189464100 1514584 101855 SH OTR 0 101855 0 CymaBay Therapeutics, Inc. Common Stock 23257D103 3893270 543753 SH OTR 0 543753 0 Gritstone Oncology, Inc. Common Stock 39868T105 34566629 3102929 SH OTR 0 3102929 0 Second Sight Medical Products, Inc. Common Stock 81362J100 3597974 4492975 SH OTR 0 4492975 0 Ocular Therapeutix, Inc. Common Stock 67576A100 9747690 2215384 SH OTR 0 2215384 0 Audentes Therapeutics, Inc. Common Stock 05070R104 20971260 553916 SH OTR 0 553916 0 CRISPR Therapeutics AG Common Stock H17182108 200122625 4248888 SH OTR 0 4248888 0 OpGen, Inc. Common Stock 68373L109 40121 102167 SH OTR 0 102167 0 Veracyte, Inc. Common Stock 92337F107 68732336 2410815 SH OTR 0 2410815 0